Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10573663 | 0.84 | TSHR (0.50) | SMN1; SMN2L3MBTL1LMNAALDH1A1KMT2A | |
| SCHEMBL513491 | 0.83 | TSHR (0.49) | CYP3A4L3MBTL1LMNAALDH1A1KMT2A | |
| SCHEMBL11027189 | 0.80 | CYP3A4 (0.38) | SMN1; SMN2CYP3A4CYP19A1L3MBTL1LMNA | |
| SCHEMBL11027636 | 0.80 | KMT2A (0.40) | SMN1; SMN2CYP3A4CYP19A1L3MBTL1LMNA | |
| SCHEMBL406969 | 0.79 | SMN1; SMN2 (0.46) | SMN1; SMN2CYP3A4CYP19A1L3MBTL1LMNA | |
| SCHEMBL10507286 | 0.77 | ALOX5 (0.51) | LMNAALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL28966334 | 0.76 | HPGD (0.47) | SMN1; SMN2L3MBTL1LMNAALDH1A1KMT2A | |
| SCHEMBL28966332 | 0.76 | HPGD (0.47) | SMN1; SMN2L3MBTL1LMNAALDH1A1KMT2A | |
| SCHEMBL11159565 | 0.74 | ALDH1A1 (0.47) | SMN1; SMN2L3MBTL1LMNAALDH1A1GRM8 | |
| SCHEMBL27764339 | 0.74 | MAPT (0.48) | SMN1; SMN2CYP3A4LMNAALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11117852-B2 | Isolation of pure cannabinoids from Cannabis | UNIVERSITY OF MISSISSIPPI (US) | 2021-09-14 | — | — | US | disclosed |
| US-20200039908-A1 | Isolation of pure cannabinoids from Cannabis | UNIVERSITY OF MISSISSIPPI | 2020-02-06 | — | — | US | disclosed |
| EP-3599831-A1 | ISOLATION OF PURE CANNABINOIDS FROM CANNABIS | University Of Mississippi (US) | 2020-02-05 | — | — | EP | disclosed |
| WO-2018187500-A1 | ISOLATION OF PURE CANNABINOIDS FROM CANNABIS | UNIVERSITY OF MISSISSIPPI (US) | 2018-10-11 | — | — | WO | disclosed |
| EP-1133688-A4 | METHOD OF PREPARING DELTA-9-TETRAHYDROCANNABINOL | UNIV MISSISSIPPI (US) | 2008-05-07 | — | — | EP | disclosed |
| US-7321047-B2 | Carbamoylating a tetrahydrocannabinol with an aryl or arylmethyl isocyanate or isothiocyanate, forming a solution of the (thio)carbamate in an organic solvent, separating the isomer of interest by crystallization, and hydrolyzing it to form the desired tetrahydrocannabinol isomer. | ALPHORA RESEARCH INC. (CA) | 2008-01-22 | — | — | US | disclosed |
| US-20060264647-A1 | Separation of tetrahydrocannabinols | SANDOZ INC. | 2006-11-23 | — | — | US | disclosed |
| EP-1472514-A4 | METHOD OF PREPARING DELTA-9 TETRAHYDROCANNABINOL | UNIV MISSISSIPPI (US) | 2006-01-04 | — | — | EP | disclosed |
| EP-1472514-A2 | METHOD OF PREPARING DELTA-9 TETRAHYDROCANNABINOL | University of Mississippi (US) | 2004-11-03 | — | — | EP | disclosed |
| US-6730519-B2 | ISOLATION TETRAHYDROCANNIBINOL FROM PLANT EXTRACT; OBTAIN PLANT SAMPLE, CHELATE TETRAHYDROCANNIBINOL TO SOLID SUPPORT, ELUTE AND RECOVER TETRAHYDROCARBANNIOL FROM SUPPORT | THE UNIVERSITY OF MISSISSIPPI | 2004-05-04 | — | — | US | disclosed |
| WO-2003061563-A2 | METHOD OF PREPARING DELTA-9 TETRAHYDROCANNABINOL | UNIVERSITY OF MISSISSIPPI (US) | 2003-07-31 | — | — | WO | disclosed |
| US-20020086438-A1 | Method of preparing delta-9-tetrahydrocannabinol | UNIVERSITY OF MISSISSIPPI, THE | 2002-07-04 | — | — | US | disclosed |
| US-20020039795-A1 | Recovering preferential particle from plants; obtain plant, generate extract, remove solvent from extract, expose extract to flash distillation, recover preferential plant particles | ELSOHLY ET AL | 2002-04-04 | — | — | US | disclosed |
| US-6365416-B1 | EFFICIENT AND ECONOMIC LARGE SCALE PRODUCTION BY SOLVENT EXTRACTION OF CANNABIS WITH NONPOLAR SOLVENT THEN CHROMATOGRAPHY AND VACUUM DISTILATION | THE UNIVERSITY OF MISSISSIPPI | 2002-04-02 | — | — | US | disclosed |
| EP-1133688-A1 | METHOD OF PREPARING DELTA-9-TETRAHYDROCANNABINOL | The university of Mississippi (US) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000025127-A1 | METHOD OF PREPARING DELTA-9-TETRAHYDROCANNABINOL | THE UNIVERSITY OF MISSISSIPPI (US) | 2000-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039908-A1 | Isolation of pure cannabinoids from Cannabis | CNR2, CNR1, FAAH | SMN1; SMN2 3075/4885CYP3A4 818/4885CYP19A1 2746/4885 |
| US-20060264647-A1 | Separation of tetrahydrocannabinols | CNR2, CNR1, CBR1 | SMN1; SMN2 3793/4885CYP3A4 89/4885CYP19A1 184/4885 |
| US-11117852-B2 | Isolation of pure cannabinoids from Cannabis | CNR2, CNR1, FAAH | SMN1; SMN2 3075/4885CYP3A4 818/4885CYP19A1 2746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.